Versor Investments’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,920
Closed -$1.18M 296
2025
Q4
$1.18M Buy
+12,920
New +$1.24M 0.18% 106
2025
Q3
Sell
-19,963
Closed -$2.09M 782
2025
Q2
$2.09M Sell
19,963
-10,529
-35% -$998K 0.37% 32
2025
Q1
$2.69M Buy
30,492
+21,392
+235% +$2.19M 0.44% 21
2024
Q4
$873K Buy
+9,100
New +$848K 0.15% 191
2024
Q3
Sell
-3,600
Closed -$310K 865
2024
Q2
$310K Buy
+3,600
New +$291K 0.06% 509
2023
Q1
Sell
-4,900
Closed -$302K 784
2022
Q4
$302K Buy
+4,900
New +$329K 0.03% 507

Other funds holding HQY

Versor Investments's HQY Position: Q1 2026 in Review

Versor Investments sold out of HealthEquity (HQY) in Q1 2026, closing a stake of 12,920 shares — an estimated $1.18M sold.

Versor Investments first reported a position in HQY in Q4 2022 and held it in 6 quarters. The position peaked at $2.69M in Q1 2025. 485 funds tracked by Wall St. Rank hold HQY as of Q1 2026.

  • Versor Investments reported no remaining HealthEquity position as of Q1 2026 after selling out during the quarter.
  • Versor Investments sold 12,920 HealthEquity shares in Q1 2026, an estimated $1.18M.
  • Versor Investments first reported a position in HealthEquity in Q4 2022 and held it in 6 quarters.
  • Versor Investments's HealthEquity position peaked at $2.69M in Q1 2025.
  • 485 funds tracked by Wall St. Rank held HealthEquity as of Q1 2026.

Based on Versor Investments's 13F filing for Q1 2026, filed 12 May 2026.